BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2009
View Archived Issues
ABI-200 developed as a topical antimicrobial alternative to mupirocin
Read More
Can-Fite BioPharma initiates preparation for phase III psoriasis trial of CF-101
Read More
MGN-1703 safe and well tolerated in phase I trial in subjects with metastatic malignancies
Read More
IMO-2055 combined with erlotinib/bevacizumab well tolerated in NSCLC patients
Read More
S/GSK-1265744 shows potent short-term antiviral efficacy in HIV-infected subjects
Read More
NAI-107 has potent in vitro/in vivo activity against multidrug-resistant Gram-positive pathogens
Read More
MBX-1684 potently inhibits the type III secretion system of P. aeruginosa in vitro
Read More
ACE-031 increases lean body mass and muscle volume in healthy postmenopausal women
Read More
Addrenex submits sNDA to FDA for Clonicel in ADHD
Read More
Hologic receives CE marking approval for ThinPrep integrated imager for cervical cancer screening
Read More
Response Genetics launches ResponseDX Gastric diagnostic test for gastric cancer
Read More
Advaxis reports results from phase I trial of ADXS11-001 vaccine in cervical cancer
Read More
Vifor reports results from phase III study of Ferinject in iron deficiency and CHF
Read More
FDA approves new indication of Bayer's Mirena for heavy menstrual bleeding
Read More
CHMP issues positive opinion for Baxter's Celvapan H1N1 pandemic influenza vaccine
Read More
FDA approves Oncolytics Biotech's SPA for phase III Reolysin trial in head and neck cancers
Read More
Medicago initiates phase I human clinical trial of avian influenza vaccine
Read More
FDA grants fast track designation to Corthera's relaxin for acute heart failure
Read More
ArQule presents update on clinical development of ARQ-197
Read More
SciClone discontinues phase II RP-101 trial in late-stage pancreatic cancer
Read More
Amicus Therapeutics reports results of phase II Plicera study for Gaucher disease
Read More
Seattle Genetics discontinues phase IIb dacetuzumab trial
Read More
Muscarinic M1 receptor allosteric modulators claimed by Merck & Co. for AD
Read More
Novel PPARgamma agonist for the treatment of diabetes described by Adamed
Read More
Histamine H1 receptor antagonists in early development at Nippon Zoki
Read More